NCT04323644 (CovidSurg) is a clinical trial of Surgery in COVID-19, sponsored by University of Birmingham.

Who is sponsoring NCT04323644?

NCT04323644 is sponsored by University of Birmingham.

What drugs are being tested in NCT04323644?

Interventions in NCT04323644: Surgery.

What condition does NCT04323644 study?

NCT04323644 studies COVID-19, Coronavirus, Surgery.

Is NCT04323644 still recruiting?

NCT04323644 is currently status unknown. Last updated 12 May 2020.

Last reviewed 2020-05-12 · How we verify

NCT04323644: CovidSurg

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg)

Status unknown Last updated 12 May 2020

What this trial tests

trial testing Surgery in COVID-19 in 1,000 participants. Status unknown.

Timeline

1 January 2020

Primary endpoint
30 September 2020

30 September 2020

Quick facts

Lead sponsor	University of Birmingham
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,000
Start date	1 January 2020
Primary completion	30 September 2020
Estimated completion	30 September 2020
Sites	1 location across Spain

Drugs / interventions tested

Surgery

Conditions studied

COVID-19 — all drugs for COVID-19 →
Coronavirus — all drugs for Coronavirus →
Surgery — all drugs for Surgery →

Sponsor

University of Birmingham

Who can join

Eligibility, any sex, with COVID-19 or Coronavirus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

CovidSurg will capture real-world international data, to determine 30-day mortality in patients with COVID-19 infection who undergo surgery. This shared international experience will inform the management of this complex group of patients who undergo surgery throughout the COVID-19 pandemic, ultimately improving their clinical care.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

The impact of COVID-19 on the provision of cardiac surgical services.
Mohamed Abdel Shafi A, Hewage S, Harky A. · · 2020 · cited 41× · PMID 32419218 · DOI 10.1111/jocs.14631
Outcomes and Their State-level Variation in Patients Undergoing Surgery With Perioperative SARS-CoV-2 Infection in the USA: A Prospective Multicenter Study.
COVIDSurg Collaborative. · · 2022 · cited 35× · PMID 34793350 · DOI 10.1097/sla.0000000000005310
Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulence and Change.
Hwang ES, Balch CM, Balch GC, Feldman SM, et al · · 2020 · cited 29× · PMID 32535870 · DOI 10.1245/s10434-020-08673-6
Acute abdomen in patients with SARS-CoV-2 infection or co-infection.
Seeliger B, Philouze G, Cherkaoui Z, Felli E, et al · · 2020 · cited 22× · PMID 32720012 · DOI 10.1007/s00423-020-01948-2
Is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) present intraperitoneally in patients with coronavirus disease 2019 (COVID-19) infection undergoing emergency operations?
Seeliger B, Philouze G, Benotmane I, Mutter D, et al · · 2020 · cited 22× · PMID 32591139 · DOI 10.1016/j.surg.2020.05.033
Outcomes after perioperative SARS-CoV-2 infection in patients with proximal femoral fractures: an international cohort study.
COVIDSurg Collaborative. · · 2021 · cited 10× · PMID 34848515 · DOI 10.1136/bmjopen-2021-050830
Cardiac Surgery Outcomes in an Epicenter of the COVID-19 Pandemic.
Farrington WJ, Robinson NB, Rahouma M, Lau C, et al · · 2022 · cited 9× · PMID 33444770 · DOI 10.1053/j.semtcvs.2021.01.005
Surgeons, plague, and leadership: A historical mantle to carry forward.
Barr J, Hwang ES, Shortell CK. · · 2020 · cited 3× · PMID 32386712 · DOI 10.1016/j.amjsurg.2020.04.042

Verify or expand the search:

Other trials of Surgery

Trials testing the same drug.

NCT07472478 — Phase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-IIIB KRAS G12 · Phase 2 · not yet recruiting
NCT07524452 — Becotatug Vedotin (MRG003) in Combination With PD-1 Inhibitor Versus PD-1 Inhibitor for the Treatment of EGFR-positive, · Phase 3 · recruiting
NCT07053033 — Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR Be · Phase 2 · recruiting
NCT07352007 — Sintilimab Combined With Stereotactic Body Radiotherapy as Neoadjuvant Therapy for Resectable Hepatocellular · Phase 2 · not yet recruiting
NCT07419932 — Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer · recruiting

Other recruiting trials for COVID-19

Currently open trials in the same condition.

NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting

Other University of Birmingham trials

Trials by the same sponsor.

NCT07160686 — Apixaban to Prevent Venous Thromboembolism in Ambulatory Lung Cancer Patients Undergoing Systemic Anticancer Treatment · Phase 3 · not yet recruiting
NCT07446166 — TETANUS Antibody Detection in Saliva Study · NA · not yet recruiting
NCT07294794 — Personalised Pharmacometabolomic-guided Strategy Trial to Optimise Treatment for Hypertension · NA · not yet recruiting
NCT07246356 — Feasibility and Efficacy of GTEP for Birth Trauma · NA · recruiting
NCT06932653 — Reducing Deaths After Surgery in Low- and Middle-income Countries: A Pilot Cluster Randomised Trial · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04323644 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Birmingham
Last refreshed: 12 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04323644.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing